Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

G Bradley Cole

Director at Castle Biosciences Inc (CSTL); Director at Kiniksa Pharmaceuticals International, plc (KNSA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $510K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 31SEC KNSAKiniksa Pharmaceuticals International, plc Sell 3,67311,672 held (−24%) $81.43 $299K -3.5%
Mar 9SEC CSTLCastle Biosciences Inc Sell 4,74821,964 held (−18%) $28.44 $135K +12.4%
Mar 9SEC CSTLCastle Biosciences Inc Sell 2,65519,309 held (−12%) $28.51 $76K +12.1%